201910.1.1 | Egypt | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Gad, 2002 | |
201910.1.2 | Egypt | 1 | | Pathogenic | | Gad, 2002 | Mother of 201910.1.1 |
201910.2.1 | Egypt | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Gad, 2002 | |
201910.2.2 | Egypt | 1 | | Pathogenic | | Gad, 2002 | Mother of 201910.2.1 |
201910.14 | Tunisia | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | Compound heterozygote |
201910.21 | Lebanon | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Carries the CL6 haplotype and two additi... |
201910.25 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Carries the CL6 haplotype and an additio... |
201910.29 | Lebanon | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Compound heterozygous with a gene conver... |
201910.30 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Carries the CL6 haplotype and an additio... |
201910.G.7 | Tunisia | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | 5 unrelated patients |